Evaluating if the improved vitamin D status through sun exposure, food or supplements could benefit Type 2 Diabetes patients according to blood test biomarkers (HbA1c)

Not Applicable

• Conditions: type 2 diabetes; vitamin D deficiency; Metabolic and Endocrine - Diabetes; Diet and Nutrition - Other diet and nutrition disorders

• Registration Number: ACTRN12620000121965
• Lead Sponsor: niversity of Technology, Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-02-10
• Last Update Posted: 17 February 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 134

Inclusion Criteria

1) Aged greater than or equal to 18 years old; 2) Diagnosed with Type 2 Diabetes in the preceding 12 months, and not on diabetic medication or insulin treatment; 3) Serum 25OHD is between 28 nmol/l and 85 nmol/l and not on vitamin D supplements or any relevant medications; 4) Do not have thyroid diseases, liver impairment, renal failure, cancer, osteoporosis, dementia, mental diseases or taking relevant medications; 5) Not pregnant or breastfeeding women.

Exclusion Criteria

1) Unable to give written informed consent or follow the instructions in current trial; 2) are already on vitamin D supplementation or relevant diabetes control medications; 3) have liver impairment, renal failure (eGFR <50 ml/min), cancer, osteoporosis, dementia, mental disease, and thyroid diseases including hyperparathyroidism, hypercalcaemia, or taking any relevant medications; 4) are < 18 years old or are pregnant or breastfeeding women. 5) are vegen and can not ingest any animal product.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Blood Glucose level through blood test [Baseline (before intervention), 3rd month(primary endpoint) and 9 months post commencement of the intervention.];HbA1c through blood test [Baseline (before intervention), 3rd month(primary endpoint) and 9 months post commencement of the intervention.];serum 25(OH)D through blood test [Baseline (before intervention), 3rd month(primary endpoint) and 9 months post commencement of the intervention.]

Secondary Outcome Measures

Name	Time	Method
il[Nil ]